Orbimed Advisors as of March 31, 2016
Portfolio Holdings for Orbimed Advisors
Orbimed Advisors holds 138 positions in its portfolio as reported in the March 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bristol Myers Squibb (BMY) | 5.1 | $487M | 7.6M | 63.88 | |
| Allergan | 4.7 | $448M | 1.7M | 268.03 | |
| Hca Holdings (HCA) | 4.7 | $448M | 5.7M | 78.05 | |
| Amgen (AMGN) | 4.5 | $431M | 2.9M | 149.93 | |
| Boston Scientific Corporation (BSX) | 4.5 | $423M | 23M | 18.81 | |
| Abbvie (ABBV) | 4.5 | $422M | 7.4M | 57.12 | |
| Biogen Idec (BIIB) | 4.2 | $397M | 1.5M | 260.32 | |
| Celgene Corporation | 4.0 | $378M | 3.8M | 100.09 | |
| Gilead Sciences (GILD) | 2.9 | $277M | 3.0M | 91.86 | |
| Alexion Pharmaceuticals | 2.7 | $260M | 1.9M | 139.22 | |
| Impax Laboratories | 2.3 | $217M | 6.8M | 32.02 | |
| Thermo Fisher Scientific (TMO) | 2.1 | $203M | 1.4M | 141.59 | |
| Incyte Corporation (INCY) | 2.1 | $200M | 2.8M | 72.47 | |
| Regeneron Pharmaceuticals (REGN) | 2.0 | $192M | 533k | 360.44 | |
| Eli Lilly & Co. (LLY) | 1.9 | $183M | 2.5M | 72.01 | |
| WellCare Health Plans | 1.9 | $177M | 1.9M | 92.75 | |
| Intuitive Surgical (ISRG) | 1.8 | $166M | 277k | 601.05 | |
| Express Scripts Holding | 1.8 | $166M | 2.4M | 68.69 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.6 | $149M | 1.9M | 79.49 | |
| Illumina (ILMN) | 1.5 | $146M | 900k | 162.11 | |
| Teva Pharmaceutical Industries (TEVA) | 1.5 | $144M | 2.7M | 53.51 | |
| Intercept Pharmaceuticals In | 1.5 | $144M | 1.1M | 128.47 | |
| Agilent Technologies Inc C ommon (A) | 1.5 | $139M | 3.5M | 39.85 | |
| Wright Medical Group Nv | 1.5 | $139M | 8.3M | 16.60 | |
| Magellan Health Services | 1.4 | $130M | 1.9M | 67.93 | |
| Ironwood Pharmaceuticals (IRWD) | 1.3 | $126M | 12M | 10.94 | |
| Pfizer (PFE) | 1.3 | $122M | 4.1M | 29.64 | |
| Cooper Companies | 1.3 | $123M | 796k | 153.97 | |
| UnitedHealth (UNH) | 1.1 | $105M | 812k | 128.90 | |
| Neurocrine Biosciences (NBIX) | 1.1 | $105M | 2.7M | 39.55 | |
| Relypsa | 1.1 | $100M | 7.4M | 13.55 | |
| Allergan Plc pfd conv ser a | 1.0 | $96M | 104k | 919.14 | |
| Achillion Pharmaceuticals | 0.9 | $91M | 12M | 7.72 | |
| Ophthotech | 0.9 | $89M | 2.1M | 42.27 | |
| BioMarin Pharmaceutical (BMRN) | 0.9 | $84M | 1.0M | 82.48 | |
| Tesaro | 0.9 | $84M | 1.9M | 44.03 | |
| Puma Biotechnology (PBYI) | 0.8 | $81M | 2.8M | 29.37 | |
| Mallinckrodt Pub | 0.8 | $80M | 1.3M | 61.28 | |
| Corvus Pharmaceuticals (CRVS) | 0.8 | $76M | 5.3M | 14.50 | |
| Insys Therapeutics | 0.8 | $73M | 4.6M | 15.99 | |
| NuVasive | 0.8 | $72M | 1.5M | 48.65 | |
| Humana (HUM) | 0.7 | $62M | 340k | 182.95 | |
| Loxo Oncology | 0.6 | $60M | 2.2M | 27.34 | |
| Johnson & Johnson (JNJ) | 0.6 | $58M | 532k | 108.20 | |
| ImmunoGen | 0.6 | $52M | 6.1M | 8.52 | |
| Shire | 0.5 | $52M | 300k | 171.90 | |
| SPDR S&P Biotech (XBI) | 0.5 | $51M | 981k | 51.66 | |
| Medtronic (MDT) | 0.5 | $50M | 666k | 75.00 | |
| Glaukos (GKOS) | 0.5 | $49M | 2.9M | 16.86 | |
| CIGNA Corporation | 0.5 | $46M | 336k | 137.24 | |
| Insmed (INSM) | 0.5 | $44M | 3.5M | 12.67 | |
| Dimension Therapeutics | 0.4 | $42M | 5.4M | 7.83 | |
| Community Health Systems (CYH) | 0.4 | $40M | 2.2M | 18.51 | |
| Bluebird Bio (BLUE) | 0.4 | $40M | 946k | 42.50 | |
| ACADIA Pharmaceuticals (ACAD) | 0.4 | $39M | 1.4M | 27.96 | |
| Dynavax Technologies (DVAX) | 0.4 | $38M | 2.0M | 19.24 | |
| Viewray (VRAYQ) | 0.4 | $34M | 8.0M | 4.30 | |
| Array BioPharma | 0.3 | $32M | 11M | 2.95 | |
| iShares NASDAQ Biotechnology Index (IBB) | 0.3 | $29M | 112k | 260.81 | |
| Otonomy | 0.3 | $28M | 1.9M | 14.92 | |
| XenoPort | 0.3 | $27M | 6.0M | 4.51 | |
| Stryker Corporation (SYK) | 0.2 | $23M | 212k | 107.29 | |
| Medivation | 0.2 | $23M | 501k | 45.98 | |
| Infinity Pharmaceuticals (INFIQ) | 0.2 | $20M | 3.7M | 5.27 | |
| Immunomedics Inc note 4.750% 2/1 | 0.2 | $20M | 30M | 0.68 | |
| Portola Pharmaceuticals | 0.2 | $19M | 938k | 20.40 | |
| Sinovac Biotech (SVA) | 0.2 | $17M | 2.7M | 6.39 | |
| Newlink Genetics Corporation | 0.2 | $15M | 817k | 18.20 | |
| Xencor (XNCR) | 0.2 | $15M | 1.1M | 13.42 | |
| D Fluidigm Corp Del (LAB) | 0.1 | $14M | 1.7M | 8.07 | |
| Affimed Therapeutics B V | 0.1 | $15M | 3.9M | 3.74 | |
| Pieris Pharmaceuticals | 0.1 | $14M | 7.3M | 1.90 | |
| Cardinal Health (CAH) | 0.1 | $14M | 166k | 81.95 | |
| Gw Pharmaceuticals Plc ads | 0.1 | $14M | 191k | 72.15 | |
| Forward Pharma A/s | 0.1 | $14M | 798k | 17.00 | |
| Baxalta Incorporated | 0.1 | $13M | 326k | 40.40 | |
| Cynapsus Therapeutics | 0.1 | $13M | 1.1M | 11.59 | |
| McKesson Corporation (MCK) | 0.1 | $12M | 77k | 157.25 | |
| eHealth (EHTH) | 0.1 | $12M | 1.3M | 9.39 | |
| EXACT Sciences Corporation (EXAS) | 0.1 | $13M | 1.9M | 6.74 | |
| Clovis Oncology | 0.1 | $13M | 661k | 19.20 | |
| Natera (NTRA) | 0.1 | $12M | 1.3M | 9.52 | |
| Merck & Co (MRK) | 0.1 | $11M | 210k | 52.91 | |
| Zimmer Holdings (ZBH) | 0.1 | $11M | 103k | 106.63 | |
| Ensign (ENSG) | 0.1 | $12M | 514k | 22.64 | |
| Jazz Pharmaceuticals (JAZZ) | 0.1 | $12M | 90k | 130.56 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 0.1 | $11M | 2.3M | 4.88 | |
| Pronai Therapeutics | 0.1 | $11M | 1.6M | 6.74 | |
| Nabriva Therapeutics | 0.1 | $12M | 1.3M | 8.96 | |
| Horizon Pharma Plc convertible security | 0.1 | $11M | 13M | 0.86 | |
| Edwards Lifesciences (EW) | 0.1 | $10M | 115k | 88.21 | |
| Inotek Pharmaceuticals | 0.1 | $10M | 1.4M | 7.40 | |
| Syndax Pharmaceuticals (SNDX) | 0.1 | $10M | 757k | 13.32 | |
| Abbott Laboratories (ABT) | 0.1 | $9.9M | 237k | 41.83 | |
| Immunomedics | 0.1 | $9.5M | 3.8M | 2.50 | |
| Sientra | 0.1 | $9.3M | 1.4M | 6.84 | |
| Cellectis S A (CLLS) | 0.1 | $9.6M | 350k | 27.50 | |
| Galapagos Nv- (GLPG) | 0.1 | $9.6M | 230k | 41.82 | |
| Aetna | 0.1 | $8.5M | 76k | 112.36 | |
| Ultragenyx Pharmaceutical (RARE) | 0.1 | $8.1M | 128k | 63.31 | |
| Intra Cellular Therapies (ITCI) | 0.1 | $8.2M | 294k | 27.80 | |
| Enanta Pharmaceuticals (ENTA) | 0.1 | $7.3M | 249k | 29.37 | |
| Synergy Pharmaceuticals | 0.1 | $6.3M | 2.3M | 2.76 | |
| Redhill Biopharma Ltd cmn | 0.1 | $6.9M | 565k | 12.25 | |
| Assembly Biosciences | 0.1 | $7.0M | 1.4M | 5.02 | |
| Incyte Corp. note 1.250 11/1 | 0.1 | $6.7M | 4.3M | 1.58 | |
| Incyte Corp note 0.375%11/1 | 0.1 | $6.6M | 4.3M | 1.55 | |
| Biotie Therapies Corp. ads | 0.1 | $7.1M | 269k | 26.39 | |
| Qiagen | 0.1 | $5.7M | 257k | 22.34 | |
| Advaxis | 0.1 | $5.7M | 637k | 9.03 | |
| Macrogenics (MGNX) | 0.1 | $5.9M | 317k | 18.75 | |
| Fluidigm Corporation convertible cor | 0.1 | $5.6M | 10M | 0.56 | |
| Valeant Pharmaceuticals Int | 0.1 | $5.1M | 195k | 26.30 | |
| Lion Biotechnologies | 0.1 | $5.2M | 1.0M | 5.08 | |
| Marinus Pharmaceuticals | 0.1 | $5.2M | 965k | 5.38 | |
| Connecture | 0.1 | $4.5M | 1.7M | 2.56 | |
| Invitae (NVTAQ) | 0.1 | $4.7M | 457k | 10.23 | |
| Seres Therapeutics (MCRB) | 0.1 | $4.4M | 167k | 26.56 | |
| Cerus Corporation (CERS) | 0.0 | $3.4M | 578k | 5.93 | |
| Mirati Therapeutics | 0.0 | $4.2M | 198k | 21.40 | |
| Ascendis Pharma A S (ASND) | 0.0 | $4.1M | 222k | 18.55 | |
| Adaptimmune Therapeutics (ADAP) | 0.0 | $3.6M | 439k | 8.13 | |
| Alimera Sciences | 0.0 | $2.6M | 1.5M | 1.75 | |
| Anacor Pharmaceuticals In | 0.0 | $2.8M | 53k | 53.45 | |
| Mylan Nv | 0.0 | $3.2M | 70k | 46.35 | |
| Uniqure Nv (QURE) | 0.0 | $2.2M | 185k | 11.88 | |
| Roka Bioscience | 0.0 | $2.2M | 3.2M | 0.69 | |
| Orexigen Therapeutics Inc. 144a 2 3/4% Due 12/1/2020 Jd1 note 2.750%12/0 | 0.0 | $2.1M | 5.2M | 0.41 | |
| Medigus | 0.0 | $1.6M | 600k | 2.68 | |
| Qlt | 0.0 | $995k | 500k | 1.99 | |
| Amarin Corporation (AMRN) | 0.0 | $536k | 350k | 1.53 | |
| Pernix Therapeutics Holdings | 0.0 | $1.1M | 1.1M | 1.05 | |
| Biolinerx Ltd-spons | 0.0 | $1.1M | 1.0M | 1.02 | |
| Biomarin Pharmaceutical Inc note 0.750%10/1 | 0.0 | $580k | 500k | 1.16 | |
| Fate Therapeutics (FATE) | 0.0 | $1.2M | 693k | 1.80 | |
| Biomarin Pharmaceutical Inc note 1.500%10/1 | 0.0 | $595k | 500k | 1.19 | |
| Cogentix Medical | 0.0 | $1.1M | 991k | 1.10 | |
| Xtant Med Holdings | 0.0 | $1.3M | 475k | 2.71 |
